Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease

The treatment of bone a vascular necrosis is a big challenge considering the youthfulness of the patients involved by necrosis in sickle cell disease and the importance of the generated disability. A vascular osteonecrosis is an epiphysis pathology which could be treated by joint replacement with success, however, multiple surgical procedures are mostly necessary during the patient’s life with a hazardous long term functional results. The treatment by autologous bone marrow grafting is an effective alternative which preserve the native joint. Using this mini-invasive high technology surgical treatment in early stages, a joint replacement could be avoided in many patients.

[1]  I. Roberts,et al.  Bone involvement in sickle cell disease , 2005, British journal of haematology.

[2]  M. Demontalembert.  Management of sickle cell disease , 2004 .

[3]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[4]  D. Bachir,et al.  The Natural History of Symptomatic Osteonecrosis in Adults with Sickle-Cell Disease , 2003, The Journal of bone and joint surgery. American volume.

[5]  P. Hernigou,et al.  Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.

[6]  T. Somervaille.  Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management , 2001 .

[7]  P. Hernigou.  Autologous bone marrow grafting of avascular osteonecrosis before collapse , 2001, Arthritis Research.

[8]  P. Revell,et al.  The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. , 2001, The Journal of bone and joint surgery. British volume.

[9]  P. Hernigou,et al.  Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. , 1999, The Journal of bone and joint surgery. British volume.

[10]  K. Kraus,et al.  Mesenchymal stem cells in osteobiology and applied bone regeneration. , 1998, Clinical orthopaedics and related research.

[11]  W. Hayes,et al.  Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  P. Reinert,et al.  Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. , 1997, The Journal of bone and joint surgery. American volume.

[13]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[14]  L. Sleeper,et al.  Sickle cell disease as a cause of osteonecrosis of the femoral head. , 1991, The New England journal of medicine.

[15]  G. Friedlaender,et al.  Orthopaedic manifestations of sickle-cell disease. , 1990, The Yale journal of biology and medicine.

[16]  A. Brooker,et al.  Total replacement of the hip for avascular necrosis in sickle cell disease. , 1989, The Journal of bone and joint surgery. British volume.

[17]  L. Fleming,et al.  Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy. , 1988, The Journal of bone and joint surgery. American volume.

[18]  W. Harris,et al.  Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. , 1969, The Journal of bone and joint surgery. American volume.

[19]  L. Diggs,et al.  Bone and Joint Lesions in Sickle‐Cell Disease , 1967, Clinical orthopaedics and related research.

[20]  V. Ingram,et al.  Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell Hæmoglobin , 1957, Nature.

[21]  Jay R Lieberman,et al.  Core decompression for osteonecrosis of the hip. , 2004, Clinical orthopaedics and related research.

[22]  D. Steinberg,et al.  A quantitative system for staging avascular necrosis. , 1995, The Journal of bone and joint surgery. British volume.

[23]  A I Caplan,et al.  Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.

[24]  D. Bachir,et al.  Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. , 1991, The Journal of bone and joint surgery. American volume.

[25]  J. Stuart,et al.  Management of sickle-cell disease , 1974, Journal of clinical pathology. Supplement.